Last reviewed · How we verify

NCT04746417

Assessment of Skeletal Maturity Using Proximal Femoral Epiphysis in Patients With Scoliosis

Recruiting now Last updated 4 December 2024
What this trial tests

trial in Idiopathic Scoliosis in 70 participants. Currently enrolling.

Timeline
1 February 2021
Primary endpoint
31 December 2025
1 February 2026

Quick facts

Lead sponsorThe University of Hong Kong
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment70
Start date1 February 2021
Primary completion31 December 2025
Estimated completion1 February 2026
Sites1 location across Hong Kong

Conditions studied

Sponsor

The University of Hong Kong

Who can join

Adults 6 to 18, any sex, with Idiopathic Scoliosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to explore the use of proximal femoral head for the assessment of skeletal maturity in patients with idiopathic scoliosis. The aim is to validate the use of the stages of proximal femoral epiphyseal closure in assessing pubertal growth landmarks in this patient cohort. The grading system of this skeletal maturity index will be established and its reliability and reproducibility in clinical use will be examined.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Using the Proximal Femur Maturity Index at Brace Initiation for Adolescent Idiopathic Scoliosis Predicts Curve Progression Risk.
    Cheung PWH, Wong JSH, Luk KDK, Cheung JPY. · · 2024 · cited 6× · PMID 38261654 · DOI 10.2106/jbjs.23.00694

Verify or expand the search:

Other recruiting trials for Idiopathic Scoliosis

Currently open trials in the same condition.

Other The University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04746417.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing